338 related articles for article (PubMed ID: 31931835)
1. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway.
Park JH; Burgess JD; Faroqi AH; DeMeo NN; Fiesel FC; Springer W; Delenclos M; McLean PJ
Mol Neurodegener; 2020 Jan; 15(1):5. PubMed ID: 31931835
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.
Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J
Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620
[TBL] [Abstract][Full Text] [Related]
4. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease.
Zhou ZD; Tan EK
Ageing Res Rev; 2020 Sep; 62():101107. PubMed ID: 32535274
[TBL] [Abstract][Full Text] [Related]
5. Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.
Pathak D; Berthet A; Bendor JT; Yu K; Sellnow RC; Orr AL; Nguyen MK; Edwards RH; Manfredsson FP; Nakamura K
eNeuro; 2017; 4(2):. PubMed ID: 28462393
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.
Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X
Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431
[TBL] [Abstract][Full Text] [Related]
7. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction.
Sumi-Akamaru H; Beck G; Shinzawa K; Kato S; Riku Y; Yoshida M; Fujimura H; Tsujimoto Y; Sakoda S; Mochizuki H
Acta Neuropathol Commun; 2016 Mar; 4():27. PubMed ID: 27030050
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
9. Measuring Mitochondrial Dysfunction Caused by Soluble α-Synuclein Oligomers.
Luth ES; Stavrovskaya IG
Methods Mol Biol; 2019; 1948():183-198. PubMed ID: 30771178
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
11. Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatment.
Rajendran M; Queralt-Martín M; Gurnev PA; Rosencrans WM; Rovini A; Jacobs D; Abrantes K; Hoogerheide DP; Bezrukov SM; Rostovtseva TK
Cell Mol Life Sci; 2022 Jun; 79(7):368. PubMed ID: 35718804
[TBL] [Abstract][Full Text] [Related]
12. Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease.
Shen Y; Wu Q; Shi J; Zhou S
Biomed Pharmacother; 2020 Dec; 132():110928. PubMed ID: 33128944
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Sirtuins in Parkinson's Disease.
He L; Wang J; Yang Y; Li J; Tu H
Neurochem Res; 2022 Jun; 47(6):1491-1502. PubMed ID: 35220492
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC.
Risiglione P; Zinghirino F; Di Rosa MC; Magrì A; Messina A
Biomolecules; 2021 May; 11(5):. PubMed ID: 34064816
[TBL] [Abstract][Full Text] [Related]
15. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
[TBL] [Abstract][Full Text] [Related]
16. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
17. Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
Morales-Prieto N; Bevans R; O'Mahony A; Barron A; Giles Doran C; McCarthy E; Concannon RM; Goulding SR; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
Aging Cell; 2024 Jun; 23(6):e14155. PubMed ID: 38529808
[TBL] [Abstract][Full Text] [Related]
18. αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.
Pozo Devoto VM; Dimopoulos N; Alloatti M; Pardi MB; Saez TM; Otero MG; Cromberg LE; Marín-Burgin A; Scassa ME; Stokin GB; Schinder AF; Sevlever G; Falzone TL
Sci Rep; 2017 Jul; 7(1):5042. PubMed ID: 28698628
[TBL] [Abstract][Full Text] [Related]
19. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease.
Portz P; Lee MK
Cells; 2021 Apr; 10(4):. PubMed ID: 33924585
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice.
Klimova N; Long A; Kristian T
J Neurosci Res; 2019 Aug; 97(8):975-990. PubMed ID: 30801823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
